Volume : 09, Issue : 04, April – 2022

Title:

47.FORMULATION, DEVELOPMENT AND EVALUATION OF ANTIFUNGAL ECONAZOLE LOADED INVASOMES GEL FOR TOPICAL FUNGAL TREATMENT
‏‬

Authors :

Durgesh Kumar Patel*, Dr. R.B. Goswami

Abstract :

Topical drug administration is a localised drug delivery system that can be used to administer drugs to any part of the body via ophthalmic, rectal, vaginal, and cutaneous channels. The principal route of topical medication delivery is through the skin, which is one of the most easily accessible organs on the human body for topical administration. Fungus can cause a variety of skin illnesses. Antifungal medications are fungicides that are used to treat mycoses such athlete’s foot, ringworm, and candidasis. Antifungal kills the fungal organism without harming the host by leveraging distinctions between mammalian and fungal cells. Hence we attempted to develop Econazole-loaded invasomes hydrogel. Invasomes were prepared by conventional thin layer evaporation technique using Phosphatidylcholine, terpene (Limonene) and ethanol. In present study was to develop and characterize Econazole -loaded invasomal drug carrier systems. Different Formulations (F1 to F6) of invasomes were prepared and evaluated for average vesicle size, zeta potential and entrapment efficiency. Drug content of econazole incorporated invasomes gel for formulation IG-1, IG-2 and IG-3 was found to be 98.85±0.15, 99.45±0.10 and 98.74±0.23 respectively. The maximum drug content was found in formulation IG-2 (99.45±0.10), select as optimized formulation. When the regression coefficient values of were compared, it was observed that ‘r2’ values of Higuchi was maximum i.e. 0.985 hence indicating drug release from formulations was found to follow Higuchi kinetics.
Key words: Econazole, Invasomes, Fungal Treatment, formulation, Evaluation

Cite This Article:

Please cite this article in press Durgesh Kumar Patel et al, Formulation, Development And Evaluation Of Antifungal Econazole Loaded Invasomes Gel For Topical Fungal Treatment., Indo Am. J. P. Sci, 2022; 09(04).,

Number of Downloads : 10

References:

1. Ameen M 2010. Epidemiology of superficial fungal infections. Clin Dermatol 28: 197–201.
2. Zimmerman LE 1955. Fatal fungus infections complicating other diseases. Am J Clin Pathol 25: 46–65.
3. Hogan DA, Muhlschlegel FA 2011. Candida albicans developmental regulation: Adenylyl cyclase as a coincidence detector of parallel signals. Curr Opin Microbiol 14: 682–686.
4. Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther. Deliv. 2010; 1: 109–131.
5. Ashtikar M, Langeluddecke L, Fahr A, Deckert V. Tip-enhanced Raman scattering for tracking of invasomes in the stratum corneum. Biochim. Et Biophys. Acta (Bba)-Gen. Subj. 2017; 1861: 2630–2639.
6. Lopez RF, Bentley MVL, Delgado-Charro MB, Guy RH. Optimization of aminolevulinic acid delivery by iontophoresis. J. Control. Release. 2003; 88: 65–70.
7. Wang S, Kara M, Krishnan T. Transdermal delivery of cyclosporin-Ausin gel ectroporation. J. Control. Release. 1998; 50: 61–70.
8. Cancel LM, Tarbell JM, Ben-Jebria A. Fluorescein permeability and electrical resistance of human skin during low frequency ultrasound application. J. Pharm. Pharmacol. 2004; 56: 1109–1118.
9. Liu H, Li S, Wang Y, Yao H, Zhang Y. Effect of vehicles and enhancers on the topical delivery of cyclosporin A. Int. J. Pharm. 2006; 311: 182–186.
10. Barry BW. Breaching the skin’s barrier to drugs. Nat. Biotechnol. 2004; 22:165.
11. Pierre MBR, Costa IDSM. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch. Dermatol. Res. 2011; 303: 607.
12. Wang J, Yuan Y, Liu C, Zhu D, Shen X, Yang B. Preparation and pharmaceutical/pharmacodynamic evaluation of topical brucine-loaded liposomal hydrogel. J. Mater. Sci. Mater. Med. 2009; 20: 2075–2084.
13. Chen M, Liu X, Fahr A. Skin penetration and deposition of carboxyfluoresce in and temoporfin from different lipid vesicular systems: In vitro study with finite and infinite dosage application. Int. J. Pharm. 2011; 408: 223–234.
14. Ota Y, Hamada A, Nakano M, Saito, H. Evaluation of percutaneous absorption of midazolambyterpenes. Drug Metab. Pharmacokinet. 2003, 18, 261–266.
15. Puglia C, Bonina F, Trapani G, Franco M, Ricci M. Evaluation of in vitro percutaneous absorption of lorazepam and clonazepam from hydro-alcoholic gel formulations. Int. J. Pharm. 2001; 228: 79–87.
16. Vaddi H, Ho P, Chan Y, Chan S. Terpenes in ethanol: Haloperidol permeation and partition through human skin and stratum corneum changes. J. Control. Release. 2002; 81: 121–133.
17. Verma D, Verma S, McElwee K, Freyschmidt-Paul P, Hoffman R, Fahr A. Treatment of alopecia areata in the DEBR model using Cyclosporin Alipidvesicles. Eur. J. Dermatol. 2004; 14:332–338.
18. Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A. Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: Characterization, stability and in vitro skin penetration studies. Colloids Surf B Biointerfaces 2009; 70:198-206.
19. Dragicevic-Curic N, Gräfe S, Gitter B, Fahr A. Efficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell lines. J Photochem Photobiol B 2010; 101:238-50.
20. Badran MM, Kuntsche J, Fahr A. Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: Dependency on needle size and applied formulation. Eur J Pharm Sci 2009; 36:511-23.
21. Haag SF, Fleige E, Chen M, Fahr A, Teutloff C, Bittl R, et al. Skin penetration enhancement of core-multishell nanotransporters and invasomes measured by electron paramagnetic resonance spectroscopy. Int J Pharm 2011; 416:223-8.
22. Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A. Temoporfinloaded invasomes: Development, characterization and in vitro skin penetration studies. J Control Release 2008; 127:59-69.
23. Dragicevic-Curic N, Friedrich M, Petersen S, Scheglmann D, Douroumis D, Plass W, et al. Assessment of fluidity of different invasomes by electron spin resonance and differential scanning calorimetry. Int J Pharm 2011; 412:85-94.
24. Ayman F. El-Kattan, Charles S. Asbill, Nanhye Kim, Bozena B. Michniak. The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. International Journal of Pharmaceutics. 2001; 215: 229 ă 240.
25. Kalpana B, Lakshmi P K. Transdermal permeation enhancement of Tolterodine tartrate through invasome and iontophoresis. Der Pharmacia Lettre, 2013; 5(6): 119 ă 126.
26. Multimer MN, Riffskin C, Hill JA, Marry E, Cyr NG and Glickman GJ. Synthesis of methylsilyl derivatives of procaine and their diffusion. J Am Pharm Assoc. Sci, 1956; 45: 212.
27. Aqil M, Ahad A, Sultana Y, Ali A. 2007. Status of terpenes as skin penetration enhancers. Drug Discov Today. 12:1061–1067.